Abstract:Background Phosphoglycerate kinase 1 (PGK1) plays a crucial role in the glycolytic pathway and its overexpression has a negative impact on tumor development and prognosis. Resveratrol, a natural polyphenolic compound, has gained significant attention in recent years due to its anti-inflammatory, antioxidant, and anti-tumor properties. However, the mechanism by which resveratrol inhibits breast cancer growth, invasion, and metastasis through the PGK1 glycolytic pathway is still not fully understood. Therefore, this study aimed to investigate the inhibitory effects of resveratrol on breast cancer cell proliferation and invasive migration, as well as its ability to promote apoptosis in vitro. Additionally, the study examined the inhibitory effects of resveratrol on the growth of mouse breast cancer graft tumors in vivo. Methods We analyzed the expression levels of glycolytic enzymes in different breast tissues and their correlation with the prognosis of breast cancer patients through GEPIA and The Human Protein Atlas database. Wound healing assay, Transwell migration and invasion assay were used to study the effect of resveratrol on the biological functions of breast cancer. RT-qPCR and Western blot methods were used to explore the potential molecular mechanism of resveratrol inhibiting the development of breast cancer through the PGK1 glycolysis pathway. In vivo experiments explore the biological mechanisms behind PGK1-mediated breast cancer proliferation and invasion. Results High expression of PGK1 is significantly associated with poor prognosis in breast cancer patients, and resveratrol induces breast cancer cell apoptosis in a dose-dependent manner, inhibiting PK, PGK1, LDH enzyme activity and ATP content. Resveratrol inhibits PGK1 expression and its related c-Myc/PI3K/AKT signaling pathway. Western blot experiments show that resveratrol affects the biological functions of breast cancer by inhibiting PCNA, MMP2 and MMP9 proteins and activating BAX/Bcl-2 and Caspase3/7 proteins. In addition, in vivo experiments show that resveratrol significantly inhibits the growth of transplanted tumors in breast cancer mice and inhibits breast cancer tumor proliferation, invasion and metastasis by downregulating PGK1 expression. Conclusion Resveratrol demonstrates inhibitory effects on breast cancer cell proliferation, invasive and migration, as well as induction of apoptosis in vitro. It also inhibits the growth of mouse breast cancer transplantation tumors in vivo and exhibits oncostatic effects both in vitro and in vivo. Moreover, resveratrol reduces the expression of PGK1 in breast cancer BT-549 cells by regulating the transcription factors c-Myc. This regulation leads to the blockage of cellular glycolysis pathways, ultimately inhibiting the malignant biological behavior of breast cancer cells.

Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated akt and caspase-9

Effect of Proliferation, Cell Cycle, and Bcl-2s of MCF-7 Cells by Resveratrol

Pterostilbene Simultaneously Induces Apoptosis, Cell Cycle Arrest and Cyto-Protective Autophagy in Breast Cancer Cells.

Resveratrol-induced apoptosis is associated with activation of p53 and inhibition of protein translation in T47D human breast cancer cells

Notch signaling mediated repressive effects of resveratrol in inducing caspasedependent apoptosis in MCF-7 breast cancer cells

Resveratrol inhibits proliferation in human colorectal carcinoma cells by inducing G1/S-phase cell cycle arrest and apoptosis through caspase/cyclin-CDK pathways

Resveratrol Inhibits Breast Cancer Stem-Like Cells and Induces Autophagy Via Suppressing Wnt/β-catenin Signaling Pathway.

Resveratrol Inhibits Oral Squamous Cell Carcinoma Through Induction of Apoptosis and G2/M Phase Cell Cycle Arrest.

Resveratrol Induces Apoptosis and Cell Cycle Arrest of Human T24 Bladder Cancer Cells in Vitro and Inhibits Tumor Growth in Vivo

Resveratrol affects protein kinase C activity and promotes apoptosis in human colon carcinoma cells.

Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death

Apoptosis-promoting effect of resveratrol combined with 5-FU on human breast cancer cell line MCF7

Resveratrol Induces Apoptosis in Breast Cancer Cells by E2f1-Mediated Up-Regulation of Aspp1

Resveratrol Induced Apoptosis in Human Gastric Carcinoma SGC‐7901 Cells Via Activation of Mitochondrial Pathway

Resveratrol inhibits proliferation, angiogenesis and induces apoptosis in colon cancer cells

Resveratrol confers resistance against taxol via induction of cell cycle arrest in human cancer cell lines.

Mechanism of Resveratrol Affecting Biological Functions of Breast Cancer Through Glycolysis Pathway

Resveratrol Enhances Inhibition Effects of Cisplatin on Cell Migration and Invasion and Tumor Growth in Breast Cancer MDA-MB-231 Cell Models In Vivo and In Vitro

Molecular mechanism of resveratrol inhibiting proliferation of human lung cancer cells through inducing cell cycle arrest and apoptosis

Resveratrol Inhibits Invasion and Metastasis of Hepatocellular Carcinoma Cells

Resveratrol Induced Apoptosis and Cell Arrest in Cancer Cells